About This Trial
Evaluating optimal booster schedules for sustained malaria protection in endemic regions.
Primary Endpoints
- Clinical malaria incidence
- Antibody persistence
Latest Update
January 2026
WHO prequalification received. Over 18 million doses shipped to endemic countries.